Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping-Ying Pan

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Biomaterials|September 14, 2024
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS stormYongbin Liu, Dongfang Yu, Xueying Ge, et al.
Cancer Research|January 21, 2006
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing hostBo Huang, Ping-Ying Pan, Qingsheng Li, et al.
Cancer Research|December 10, 2009
Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancerPing-Ying Pan, Ge Ma, Kaare J Weber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2021
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived CellsLouis Hinkle, Yongbin Liu, Chaoyang Meng, et al.
Stem Cells (Dayton, Ohio)|January 15, 2010
Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cellsZuping Zhou, Deborah L French, Ge Ma, et al.
Frontiers in Immunology|June 27, 2022
Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill <i>Mycobacterium tuberculosis</i>Vipul K Singh, Arshad Khan, Yitian Xu, et al.
NPJ Breast Cancer|March 9, 2022
Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6Andrew W Chung, Anthony J Kozielski, Wei Qian, et al.
Cancer Research|March 12, 2009
The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapiesJunko Ozao-Choy, Ge Ma, Johnny Kao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Myeloid-derived suppressor cells prevent type 1 diabetes in murine modelsBingjiao Yin, Ge Ma, Chun-Yu Yen, et al.
Cancer Research Communications|March 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell ProfilesYitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Biomaterials|September 14, 2024
Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS stormYongbin Liu, Dongfang Yu, Xueying Ge, et al.
Cancer Research|January 21, 2006
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing hostBo Huang, Ping-Ying Pan, Qingsheng Li, et al.
Cancer Research|December 10, 2009
Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancerPing-Ying Pan, Ge Ma, Kaare J Weber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2021
The Sympathetic Nervous System Modulates Cancer Vaccine Activity through Monocyte-Derived CellsLouis Hinkle, Yongbin Liu, Chaoyang Meng, et al.
Stem Cells (Dayton, Ohio)|January 15, 2010
Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cellsZuping Zhou, Deborah L French, Ge Ma, et al.
Frontiers in Immunology|June 27, 2022
Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill <i>Mycobacterium tuberculosis</i>Vipul K Singh, Arshad Khan, Yitian Xu, et al.
NPJ Breast Cancer|March 9, 2022
Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6Andrew W Chung, Anthony J Kozielski, Wei Qian, et al.
Cancer Research|March 12, 2009
The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapiesJunko Ozao-Choy, Ge Ma, Johnny Kao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2010
Myeloid-derived suppressor cells prevent type 1 diabetes in murine modelsBingjiao Yin, Ge Ma, Chun-Yu Yen, et al.
Cancer Research Communications|March 16, 2023
Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell ProfilesYitian Xu, Licheng Zhang, Jose Thaiparambil, et al.
Pageof 5